Oruka Therapeutics, Inc. (ORKA)
NASDAQ: ORKA · Real-Time Price · USD
33.65
+0.68 (2.06%)
At close: Mar 9, 2026, 4:00 PM EDT
33.65
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:10 PM EDT
Oruka Therapeutics Market Cap
Oruka Therapeutics has a market cap or net worth of $1.63 billion as of March 9, 2026. Its market cap has increased by 312.62% in one year.
Market Cap
1.63B
Enterprise Value
1.13B
1-Year Change
312.62%
Ranking
Category
Stock Price
$33.65
Market Cap Chart
Since August 30, 2024, Oruka Therapeutics's market cap has increased from $849.32M to $1.63B, an increase of 91.80%. That is a compound annual growth rate of 53.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 1.60B | 8.78% |
| Dec 31, 2025 | 1.47B | 116.22% |
| Dec 31, 2024 | 678.62M | -20.10% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immunocore Holdings | 1.67B |
| Sionna Therapeutics | 1.66B |
| AnaptysBio | 1.65B |
| Novavax | 1.64B |
| Agios Pharmaceuticals | 1.64B |
| Innoviva | 1.63B |
| Harmony Biosciences Holdings | 1.63B |
| Intellia Therapeutics | 1.63B |